Cite
APA Citation
Furman, R. R., Luan, Y., Bilotti, E., & Graef, T. (2017). extended follow-up with the Bruton's tyrosine kinase inhibitor ibrutinib in previously treated Waldenström's macroglobulinemia. Leukemia & lymphoma, 58(6), 1502–1505. http://access.bl.uk/ark:/81055/vdc_100042870929.0x00005c